$47.31
3.28% today
NYSE, Apr 04, 09:18 pm CET
ISIN
BMG3922B1072
Symbol
G

Genpact Limited Target price 2025 - Analyst rating & recommendation

Genpact Limited Classifications & Recommendation:

Buy
42%
Hold
50%
Sell
8%

Genpact Limited Price Target

Target Price $58.56
Price $48.91
Potential
Number of Estimates 9
9 Analysts have issued a price target Genpact Limited 2026 . The average Genpact Limited target price is $58.56. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 5 Analysts recommend Genpact Limited to buy, 6 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Genpact Limited stock has an average upside potential 2026 of . Most analysts recommend the Genpact Limited stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 4.76 5.09
6.46% 6.83%
EBITDA Margin 16.21% 18.62%
1.68% 14.86%
Net Margin 10.45% 10.63%
21.50% 1.75%

10 Analysts have issued a sales forecast Genpact Limited 2025 . The average Genpact Limited sales estimate is

$5.1b
Unlock
. This is
6.83% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.1b 7.73%
Unlock
, the lowest is
$5.1b 6.43%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $4.8b 6.46%
2025
$5.1b 6.83%
Unlock
2026
$5.5b 7.47%
Unlock
2027
$6.0b 9.07%
Unlock

7 Analysts have issued an Genpact Limited EBITDA forecast 2025. The average Genpact Limited EBITDA estimate is

$948m
Unlock
. This is
22.72% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.0b 31.74%
Unlock
, the lowest is
$864m 11.85%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $772m 8.26%
2025
$948m 22.72%
Unlock
2026
$1.0b 9.12%
Unlock
2027
$1.2b 12.08%
Unlock

EBITDA Margin

2024 16.21% 1.68%
2025
18.62% 14.86%
Unlock
2026
18.91% 1.56%
Unlock
2027
19.43% 2.75%
Unlock

7 Genpact Limited Analysts have issued a net profit forecast 2025. The average Genpact Limited net profit estimate is

$541m
Unlock
. This is
8.69% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$548m 10.00%
Unlock
, the lowest is
$536m 7.72%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $498m 16.42%
2025
$541m 8.69%
Unlock
2026
$598m 10.55%
Unlock
2027
$673m 12.47%
Unlock

Net Margin

2024 10.45% 21.50%
2025
10.63% 1.75%
Unlock
2026
10.93% 2.82%
Unlock
2027
11.27% 3.11%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 2.85 3.10
16.42% 8.77%
P/E 15.79
EV/Sales 1.84

7 Analysts have issued a Genpact Limited forecast for earnings per share. The average Genpact Limited EPS is

$3.10
Unlock
. This is
8.77% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$3.13 9.82%
Unlock
, the lowest is
$3.07 7.72%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $2.85 16.42%
2025
$3.10 8.77%
Unlock
2026
$3.42 10.32%
Unlock
2027
$3.85 12.57%
Unlock

P/E ratio

Current 17.17 78.11%
2025
15.79 8.04%
Unlock
2026
14.28 9.56%
Unlock
2027
12.70 11.06%
Unlock

Based on analysts' sales estimates for 2025, the Genpact Limited stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.97 27.92%
2025
1.84 6.60%
Unlock
2026
1.71 6.95%
Unlock
2027
1.57 8.31%
Unlock

P/S ratio

Current 1.80 35.52%
2025
1.69 6.39%
Unlock
2026
1.57 6.95%
Unlock
2027
1.44 8.32%
Unlock

Current Genpact Limited Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Mizuho
Locked
Locked
Locked Feb 10 2025
Needham
Locked
Locked
Locked Feb 07 2025
Jefferies
Locked
Locked
Locked Jan 21 2025
Needham
Locked
Locked
Locked Nov 11 2024
Baird
Locked
Locked
Locked Nov 08 2024
TD Cowen
Locked
Locked
Locked Nov 08 2024
Baird
Locked
Locked
Locked Oct 09 2024
Analyst Rating Date
Locked
Mizuho:
Locked
Locked
Feb 10 2025
Locked
Needham:
Locked
Locked
Feb 07 2025
Locked
Jefferies:
Locked
Locked
Jan 21 2025
Locked
Needham:
Locked
Locked
Nov 11 2024
Locked
Baird:
Locked
Locked
Nov 08 2024
Locked
TD Cowen:
Locked
Locked
Nov 08 2024
Locked
Baird:
Locked
Locked
Oct 09 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today